But the above assumption can't be correct given that it still costs $1000 for a full sequence according the the parent article. Can anyone clarify ?
But the above assumption can't be correct given that it still costs $1000 for a full sequence according the the parent article. Can anyone clarify ?
If you want to know how your genome differs versus what's called the "reference genome," then you'd need a whole-genome sequence. That process shards up your genome, sequences it, aligns the pieces back to the human reference, and then calculates a "consensus" that represents the software's best guess as to how your genome relates to the reference.
Then they could provide you with a diff of the consensus with respect to the reference, which would probably be distributed to you in a VCF file (variant call format).
This process is the one that costs more money versus 23andMe's $99.